OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Interplay between inflammation and cancer
Rekha Khandia, Ashok Munjal
Advances in protein chemistry and structural biology (2019), pp. 199-245
Closed Access | Times Cited: 209

Showing 1-25 of 209 citing articles:

Effects of immune cells and cytokines on inflammation and immunosuppression in the tumor microenvironment
Lihong Li, Rui Yu, Tiange Cai, et al.
International Immunopharmacology (2020) Vol. 88, pp. 106939-106939
Closed Access | Times Cited: 270

Global prevalence and epidemiological trends of Hashimoto's thyroiditis in adults: A systematic review and meta-analysis
Xiaojie Hu, Yuquan Chen, Yiting Shen, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 129

Emerging mechanisms of pyroptosis and its therapeutic strategy in cancer
Liqing Lu, Ye Zhang, Xuemei Tan, et al.
Cell Death Discovery (2022) Vol. 8, Iss. 1
Open Access | Times Cited: 78

Roles of reactive oxygen species in inflammation and cancer
Yunfei Yu, Shengzhuo Liu, Luchen Yang, et al.
MedComm (2024) Vol. 5, Iss. 4
Open Access | Times Cited: 30

Unveiling the Link Between Chronic Inflammation and Cancer
Siddhant Tripathi, Yashika Sharma, Dileep Kumar
Metabolism Open (2025) Vol. 25, pp. 100347-100347
Open Access | Times Cited: 2

Macrophages in pancreatitis: Mechanisms and therapeutic potential
Fenglin Hu, Ni Lou, Juying Jiao, et al.
Biomedicine & Pharmacotherapy (2020) Vol. 131, pp. 110693-110693
Open Access | Times Cited: 112

A Systematic Review of the Biological Effects of Cordycepin
Masar Radhi, Sadaf Ashraf, Steven Lawrence, et al.
Molecules (2021) Vol. 26, Iss. 19, pp. 5886-5886
Open Access | Times Cited: 61

Therapeutic Influence on Important Targets Associated with Chronic Inflammation and Oxidative Stress in Cancer Treatment
Маргарита Е. Неганова, Junqi Liu, Yulia Aleksandrova, et al.
Cancers (2021) Vol. 13, Iss. 23, pp. 6062-6062
Open Access | Times Cited: 60

Emerging Roles of the Iron Chelators in Inflammation
Alessandra Di Paola, Chiara Tortora, Maura Argenziano, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 14, pp. 7977-7977
Open Access | Times Cited: 53

Cancer Risk in Hashimoto’s Thyroiditis: a Systematic Review and Meta-Analysis
Xiaojie Hu, Xuanyu Wang, Yue Liang, et al.
Frontiers in Endocrinology (2022) Vol. 13
Open Access | Times Cited: 46

Monocyte-to-lymphocyte ratio predicts mortality and cardiovascular mortality in the general population
Hua Yang, Jin-Yu Sun, Yu-Xuan Lou, et al.
International Journal of Cardiology (2023) Vol. 379, pp. 118-126
Closed Access | Times Cited: 35

Potential use of antioxidants for the treatment of chronic inflammatory diseases
Alexander V. Blagov, Volha I. Summerhill, Vasily N. Sukhorukov, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 13

Inflammation and cancer: friend or foe?
Andrés David Turizo-Smith, Samantha Córdoba-Hernandez, Lidy Vannessa Mejía-Guarnizo, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 12

Curcumin in Cancer and Inflammation: An In-Depth Exploration of Molecular Interactions, Therapeutic Potentials, and the Role in Disease Management
Dong‐Oh Moon
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 5, pp. 2911-2911
Open Access | Times Cited: 11

New 1,2,4-triazole based eugenol derivatives as antiCOX-2 and anticancer agents
Mohammad Mahboob Alam
Journal of Umm Al-Qura University for Applied Sciences (2024) Vol. 10, Iss. 3, pp. 555-566
Open Access | Times Cited: 9

Phytochemical synergies in BK002: advanced molecular docking insights for targeted prostate cancer therapy
Moon Nyeo Park, Jinwon Choi, Md. Maharub Hossain Fahim, et al.
Frontiers in Pharmacology (2025) Vol. 16
Open Access | Times Cited: 1

The Diagnostic and Prognostic Role of Inflammatory Markers, Including the New Cumulative Inflammatory Index (IIC) and Mean Corpuscular Volume/Lymphocyte (MCVL), in Colorectal Adenocarcinoma
Robert-Emmanuel Șerban, Dragoş-Marian Popescu, Mihail Virgil Boldeanu, et al.
Cancers (2025) Vol. 17, Iss. 6, pp. 990-990
Open Access | Times Cited: 1

Bioactive Compounds from the Zingiberaceae Family with Known Antioxidant Activities for Possible Therapeutic Uses
Raphael N. Alolga, Feizuo Wang, Xinyao Zhang, et al.
Antioxidants (2022) Vol. 11, Iss. 7, pp. 1281-1281
Open Access | Times Cited: 30

The SIRT1-HMGB1 axis: Therapeutic potential to ameliorate inflammatory responses and tumor occurrence
Lanyi Wei, Wenrui Zhang, Yueyang Li, et al.
Frontiers in Cell and Developmental Biology (2022) Vol. 10
Open Access | Times Cited: 30

Hypoxia signaling in hepatocellular carcinoma: Challenges and therapeutic opportunities
Shant Qinxiang Sin, Chakrabhavi Dhananjaya Mohan, Robby Miguel Goh, et al.
Cancer and Metastasis Reviews (2022) Vol. 42, Iss. 3, pp. 741-764
Closed Access | Times Cited: 29

Prospective Epigenetic Actions of Organo-Sulfur Compounds against Cancer: Perspectives and Molecular Mechanisms
Shoaib Shoaib, Mohammad Azam Ansari, Mohammed Ghazwani, et al.
Cancers (2023) Vol. 15, Iss. 3, pp. 697-697
Open Access | Times Cited: 19

Page 1 - Next Page

Scroll to top